Study Reveals Broad Benefits and Risks of GLP-1 Weight-Loss Drugs

New research highlights potential advantages for cognitive and cardiovascular health but warns of serious side effects like pancreatitis and kidney issues.

• A comprehensive study of nearly 2 million patients found GLP-1 drugs reduce risks for 42 health conditions, including Alzheimer's, addiction, and cardiovascular issues.
• The drugs, initially developed for diabetes, are now widely used for weight loss, with 1 in 8 Americans reporting past or current use.
• Key benefits include reduced inflammation in the brain, improved impulse control, and lower risks of suicidal ideation and substance use disorders.
• Serious side effects identified include gastrointestinal issues, kidney stones, drug-induced pancreatitis, and low blood pressure, requiring careful patient monitoring.
• Researchers emphasize the need for long-term studies to evaluate risks, benefits, and effectiveness of newer GLP-1 formulations.

3 Articles

UPI USA TODAY The Conversation